West Pharmaceuticals Lifts Full-Year Forecast as Obesity and Diabetes Device Sales Surge
West Pharmaceuticals (WST) raises its 2025 outlook after strong demand for self-injection devices drives revenue and profit above expectations.
/ 1 item
#WST↓